Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05752513
Other study ID # MS-345-2022
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 23, 2023
Est. completion date May 1, 2023

Study information

Verified date February 2023
Source Cairo University
Contact Abdalla Mousa, Lecturer
Phone 01277664430
Email Dr_abdallamousa@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Thirty-six singleton pregnant women with PAS and bladder invasion; total anterior or anterolateral invasion, who were scheduled for cesarean hysterectomy were randomly assigned into two equal groups - Group 1: included 18 pregnant women scheduled for classical cesarean hysterectomy for placenta accreta with or without ligation of anterior division of internal iliac artery before cesarean section. - Group 2: included 18 pregnant women scheduled for bladder last cesarean hysterectomy with or without ligation of anterior division of internal iliac artery.


Recruitment information / eligibility

Status Recruiting
Enrollment 36
Est. completion date May 1, 2023
Est. primary completion date May 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: 1. Age: reproductive age. 2. Pregnant with singleton living fetus. 3. Previous one or more cesarean sections. 4. Gestational age: > 34 weeks. 5. Elective or non-emergency cesarean sections. 6. Preoperative hemoglobin more than 9.5 gm/dl. Exclusion Criteria: Women with history of any medical disorder with pregnancy eg. gestational diabetes, hypertension, or anemia.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Late bladder dissection
The bladder dissection is reserved as the last step of the cesarean hysterectomy with excellent dissection of the ureteric course till the ureteric tunnel to reduce the incidence of inadvertent ureteric clamping during uterine vessel ligating and transection
early bladder dissection
The bladder dissection is early as in classic cesarean hysterectomy

Locations

Country Name City State
Egypt Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amount of blood loss during cesarean hysterectomy
Secondary Operative time during cesarean hysterectomy
Secondary bladder injury during cesarean hysterectomy
Secondary ureteric injury during cesarean hysterectomy
Secondary Need for massive blood transfusion during cesarean hysterectomy
See also
  Status Clinical Trial Phase
Withdrawn NCT04927988 - Blood Components Changes by Using of Ringer's Lactated as Detergent In Autologous Blood Cell Transfusion N/A
Not yet recruiting NCT04525001 - MOGGE PAR Scores for Prediction of Outcomes of PAS
Completed NCT04427592 - New Conservative Technique for Placenta Accreta Spectrum N/A
Completed NCT04314791 - Accuracy of Placenta Accreta Index in Diagnosing Placenta Accreta Spectrum
Completed NCT06356493 - Prophylactic Occlusion Balloons of Both Internal Iliac Arteries in Caesarean Hysterectomy for PASD
Recruiting NCT06383923 - Risk Factors, Prognosis and Prediction Models for Placenta Accreta Without Prior Cesarean Section
Not yet recruiting NCT04229953 - Accuracy of Three /Four-dimensional Ultrasound in Diagnosing Placenta Accreta Spectrum
Completed NCT05500404 - Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study
Recruiting NCT05510076 - Evaluation of Different Surgical Approaches Used for Conservative Management of Placenta Accreta Spectrum in Sohag University Hospital
Not yet recruiting NCT05481606 - Cesarean Scar Pregnancy and Clinical Outcomes
Recruiting NCT04866888 - Placenta Accreta Spectrum Outcome After Uterine Conservation N/A